Insider · CIK 0002036536
Mark Adamchak
Files at BNGO (Bionano Genomics, Inc.). First filing -, latest -.
In brief
Mark Adamchak files SEC Form 4 as officer at BNGO (Bionano Genomics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Mark Adamchak has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 7 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 3, 2026 | BNGO Bionano Genomics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +5,000 | $0.00 | $0 | 5,000 | Aug 5, 2026 |
| Jun 3, 2026 | BNGO Bionano Genomics, Inc. | FTax withholding Common Stock | -7 | $1.30 | $9 | 253 | Jun 3, 2026 |
| Feb 17, 2026 | BNGO Bionano Genomics, Inc. | FTax withholding Common Stock | -3 | $1.10 | $3 | 260 | Feb 18, 2026 |
| Feb 2, 2026 | BNGO Bionano Genomics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +10,890 | $0.00 | $0 | 10,890 | Feb 4, 2026 |
| Jun 3, 2025 | BNGO Bionano Genomics, Inc. | FTax withholding Common Stock | -7 | $3.69 | $26 | 263 | Jun 3, 2025 |
| Mar 14, 2025 | BNGO Bionano Genomics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +3,029 | $0.00 | $0 | 3,029 | Mar 18, 2025 |
| Feb 15, 2025 | BNGO Bionano Genomics, Inc. | FTax withholding Common Stock | -4 | $5.73 | $23 | 270 | Feb 19, 2025 |
Questions about Mark Adamchak
Answered from the filings on this page, as of the latest one.
Is Mark Adamchak buying or selling?
Mark Adamchak has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Mark Adamchak's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Mark Adamchak has 0.
Where does Mark Adamchak file Form 4?
Mark Adamchak has filed Form 4 at BNGO (Bionano Genomics, Inc.) as Principal Accounting Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.